White label ELPA - ClinicalTrials.eu

Study on Pembrolizumab, Etoposide, and Cisplatin or Carboplatin for First-Line Treatment in Patients with Extensive-Stage Small Cell Lung Cancer

Not recruiting

2 1 1 1
Investigated Drugs:
Study on the Effectiveness and Safety of Apalutamide, Abiraterone Acetate, and Prednisone for Patients with Metastatic Castration-resistant Prostate Cancer

Not recruiting

3 1 1
Investigated Diseases:
- Prostate cancer metastatic
Investigated Drugs:
Study on Nipocalimab for Adults with Active Inflammatory Muscle Diseases

Not recruiting

2 1
Investigated Drugs:
- Nipocalimab
+1
Study on Efgartigimod Alfa and Prednisone for Adults with Bullous Pemphigoid

Not recruiting

4 1 1
Investigated Diseases:
- Pemphigoid
Investigated Drugs:
- Efgartigimod Alfa
- Prednisone
+8
Study of Pembrolizumab and Chemotherapy for Patients with Recurrent Platinum-Sensitive Low-Grade Serous Ovarian Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:
- Pembrolizumab
Study on the Effectiveness and Safety of Vibozilimod for Adults with Moderate to Severe Plaque Psoriasis

Not recruiting

2 1
Investigated Diseases:
- Psoriasis
Investigated Drugs:
- Vibozilimod
Study of Pembrolizumab and Enfortumab Vedotin with Surgery vs. Surgery Alone for Patients with Muscle-Invasive Bladder Cancer Who Cannot or Choose Not to Use Cisplatin

Not recruiting

3 1 1 1
Investigated Diseases:
- Bladder cancer
Investigated Drugs:
- Pembrolizumab
+4
Study on the Long-Term Safety of PTC923 (Sepiapterin) for Patients with Phenylketonuria

Not recruiting

3 1 1
Investigated Drugs:
- (S)-2-Amino-6-(2-Hydroxypropanoyl)-7,8-Dihydropteridin-4(3H)-One
+4
Study on Preventing Infections After Abdominal Surgery Using D-PLEX with Doxycycline Hyclate for Patients Undergoing Abdominal Surgery

Not recruiting

3 1 1
Investigated Diseases:
- Postoperative wound infection
Investigated Drugs:
- Doxycycline Hyclate
+1
Study on the Effectiveness and Safety of Tisagenlecleucel for Adults with Hard-to-Treat or Returning Follicular Lymphoma

Not recruiting

2 1 1 1
Investigated Drugs:
- Tisagenlecleucel
+1

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies